Literature DB >> 35945928

Experimental and theoretical studies of new Co(III) complexes of hydrazide derivatives proposed as multi-target inhibitors of SARS-CoV-2.

Sakineh Parvarinezhad1, Mehdi Salehi1, Maciej Kubicki2, Rahimeh Eshaghi Malekshah3.   

Abstract

Cobalt(III) complexes with Schiff base ligands derived from hydrazone, (HL 1  = (E)-N'-(3,5-dichloro-2-hydroxybenzylidene)-4-hydroxybenzohydrazide, HL 2  = (E)-N'-(3,5-dichloro-2-hydroxybenzylidene)-4-hydroxybenzohydrazide (3,5-dibromo-2-hydroxybenzylidene), and HL 3  = (E)-4-hydroxy-N'-(2-hydroxy-3-ethoxybenzylidene)benzohydrazide), were synthesized and characterized by elemental analysis, Fourier transform infrared (FT-IR) spectroscopy, UV-Vis spectroscopy, and cyclic voltammetry. X-ray diffraction was used to determine the single crystal structure of the complex (1). Co(III) was formed in a distorted, very regular octahedral coordination in this complex; three pyridine moieties complete this geometry. Schiff base complexes' redox behaviors are represented by irreversible (1), quasi-reversible (2), and quasi-reversible (3) voltammograms. A density functional theory (DFT)/B3LYP method was used to optimize cobalt complexes with a base set of 6-311G. Furthermore, fragments occupying the highest occupied molecular orbital (HOMO) and lowest unoccupied molecular orbital (LUMO) were investigated at the same theoretical level. Quantum theory of atoms in molecules (QTAIM) computations were also done to study the coordination bonds and non-covalent interactions in the investigated structures. Hirshfeld surface analysis was used to investigate the nature and types of intermolecular exchanges in the crystal structure of the complex (1). The capacity of cobalt complexes to bind to the major protease SARS-CoV-2 and the molecular targets of human angiotensin-converting enzyme-2 (ACE-2) was investigated using molecular docking. The molecular simulation methods used to assess the probable binding states of cobalt complexes revealed that all three complexes were stabilized in the active envelope of the enzyme by making distinct interactions with critical amino acid residues. Interestingly, compound (2) performed better with both molecular targets and the total energy of the system than the other complexes.
© 2022 John Wiley & Sons Ltd.

Entities:  

Keywords:  4‐hydroxybenzohhydrazide; Co(III) complex; X‐ray crystallography; electrochemical properties; theoretical study

Year:  2022        PMID: 35945928      PMCID: PMC9353290          DOI: 10.1002/aoc.6836

Source DB:  PubMed          Journal:  Appl Organomet Chem        ISSN: 0268-2605            Impact factor:   4.072


  38 in total

1.  AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading.

Authors:  Oleg Trott; Arthur J Olson
Journal:  J Comput Chem       Date:  2010-01-30       Impact factor: 3.376

2.  Synthesis, characterization and cytotoxic activity of novel copper(II) complexes with aroylhydrazone derivatives of 2-Oxo-1,2-dihydrobenzo[h]quinoline-3-carbaldehyde.

Authors:  Eswaran Ramachandran; Valentina Gandin; Roberta Bertani; Paolo Sgarbossa; Karuppannan Natarajan; Nattamai S P Bhuvanesh; Alfonso Venzo; Alfonso Zoleo; Antonella Glisenti; Alessandro Dolmella; Alberto Albinati; Cristina Marzano
Journal:  J Inorg Biochem       Date:  2018-02-02       Impact factor: 4.155

Review 3.  What is the covalency of hydrogen bonding?

Authors:  Sławomir Janusz Grabowski
Journal:  Chem Rev       Date:  2011-02-15       Impact factor: 60.622

4.  Synthesis, characterization and anti-tubercular activity of ferrocenyl hydrazones and their β-cyclodextrin conjugates.

Authors:  Prasad Dandawate; Kiranmayi Vemuri; Ejazuddin M Khan; Manjula Sritharan; Subhash Padhye
Journal:  Carbohydr Polym       Date:  2014-03-19       Impact factor: 9.381

5.  Synthesis and antifungal activity of substituted salicylaldehyde hydrazones, hydrazides and sulfohydrazides.

Authors:  Gregory L Backes; Donna M Neumann; Branko S Jursic
Journal:  Bioorg Med Chem       Date:  2014-07-23       Impact factor: 3.641

6.  Biological activity and coordination modes of copper(II) complexes of Schiff base-derived coumarin ligands.

Authors:  Bernadette Sarah Creaven; Eszter Czeglédi; Michael Devereux; Éva Anna Enyedy; Agnieszka Foltyn-Arfa Kia; Dariusz Karcz; Andrew Kellett; Siobhán McClean; Nóra Veronika Nagy; Andy Noble; Antal Rockenbauer; Terézia Szabó-Plánka; Maureen Walsh
Journal:  Dalton Trans       Date:  2010-10-15       Impact factor: 4.390

7.  A systematic investigation on biological activities of a novel double zwitterionic Schiff base Cu(II) complex.

Authors:  S Thalamuthu; B Annaraj; M A Neelakantan
Journal:  Spectrochim Acta A Mol Biomol Spectrosc       Date:  2013-08-28       Impact factor: 4.098

8.  Synthesis, crystal structures and characterization of late first row transition metal complexes derived from benzothiazole core: anti-tuberculosis activity and special emphasis on DNA binding and cleavage property.

Authors:  Priya P Netalkar; Sandeep P Netalkar; Srinivasa Budagumpi; Vidyanand K Revankar
Journal:  Eur J Med Chem       Date:  2014-03-31       Impact factor: 6.514

9.  Synthesis, characterization of 1,2,4-triazole Schiff base derived 3d-metal complexes: Induces cytotoxicity in HepG2, MCF-7 cell line, BSA binding fluorescence and DFT study.

Authors:  Prateek Tyagi; Monika Tyagi; Swati Agrawal; Sulekh Chandra; Himanshu Ojha; Mallika Pathak
Journal:  Spectrochim Acta A Mol Biomol Spectrosc       Date:  2016-08-08       Impact factor: 4.098

10.  Several coumarin derivatives and their Pd(ii) complexes as potential inhibitors of the main protease of SARS-CoV-2, an in silico approach.

Authors:  Dejan A Milenković; Dušan S Dimić; Edina H Avdović; Zoran S Marković
Journal:  RSC Adv       Date:  2020-09-23       Impact factor: 4.036

View more
  1 in total

1.  Experimental and theoretical studies of new Co(III) complexes of hydrazide derivatives proposed as multi-target inhibitors of SARS-CoV-2.

Authors:  Sakineh Parvarinezhad; Mehdi Salehi; Maciej Kubicki; Rahimeh Eshaghi Malekshah
Journal:  Appl Organomet Chem       Date:  2022-08-08       Impact factor: 4.072

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.